The relationship between uric acid and metabolic syndrome in normal glucose tolerance and normal fasting glucose subjects

Acta Diabetologica

Volumn 48, Issue 1, 2011, Pages 79-88

  Meshkani, Reza ^a   Zargari, Mehryar ^b   Larijani, Bagher ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Body mass index; Insulin resistance; Metabolic syndrome; Uric acid

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; HYPERURICEMIA; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PREDICTION; PRIORITY JOURNAL; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; AGED; BLOOD GLUCOSE; BODY MASS INDEX; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; TRIGLYCERIDES; URIC ACID; YOUNG ADULT;

EID: 79953305313     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-010-0231-3     Document Type: Article

References (50)

1. GM Reaven 2005 The insulin resistance syndrome: definition, dietary approaches to treatment Ann Rev Nut 25 391 406 10.1146/annurev.nutr.24.012003. 132155 1:CAS:528:DC%2BD2MXpvF2mt74%3D (Pubitemid 41209007)
2. KJ Hunt RG Resendez K Williams SM Haffner MP Stern 2004 National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study Circulation 110 1251 1257 15326061 10.1161/01.CIR. 0000140762.04598.F9 (Pubitemid 39202341)
3. JM Dekker C Girman T Rhodes, et al. 2005 Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study Circulation 112 666 673 16061755 10.1161/CIRCULATIONAHA.104.516948 (Pubitemid 41099045)
4. J Butler N Rodondi Y Zhu, et al. 2006 Metabolic syndrome and the risk of cardiovascula disease in older adults J Am Coll Cardiol 47 1595 1602 16630996 10.1016/j.jacc.2005.12.046
5. JB Meigs MA Mittleman DM Nathan, et al. 2000 Hyperinsulinemia, hyperglycemia, and impaired hemostasis: The Framingham Offspring Study JAMA 283 221 228 10634338 10.1001/jama.283.2.221 1:STN:280:DC%2BD3c%2Fpslyjtg%3D%3D (Pubitemid 30039222)
6. V Ramakrishna R Jailkhani 2008 Oxidative stress in non-insulin-dependent diabetes mellitus (NIDDM) patients Acta Diabetol 45 41 46 17924055 10.1007/s00592-007-0018-3 1:CAS:528:DC%2BD1cXhs1ylurs%3D (Pubitemid 351238275)
7. CC Fu DA Wu JH Wang WC Yang CH Tseng 2009 Association of C-reactive protein and hyperuricemia with diabetic nephropathy in Chinese type 2 diabetic patients Acta Diabetol 46 127 134 18853099 10.1007/s00592-008-0069-0 1:CAS:528:DC%2BD1MXlsFKksrc%3D
8. Guo L, Cheng Y, Wang X, Pan Q, Li H, Zhang L, Wang Y (2010) Association between microalbuminuria and cardiovascular disease in type 2 diabetes mellitus of the Beijing Han nationality. Acta Diabetol (in press)
9. GT Ko CS Cockram CC Chow, et al. 2005 High prevalence of metabolic syndrome in Hong Kong Chinese-comparison of three diagnostic criteria Diabetes Res Clin Pract 69 160 168 16005365 10.1016/j.diabres.2004.11.015 (Pubitemid 40943481)
10. D Simmons CF Thompson 2004 Prevalence of the metabolic syndrome among adult New Zealanders of Polynesian and European descent Diabetes Care 27 3002 3004 15562227 10.2337/diacare.27.12.3002 (Pubitemid 39565079)
11. F Azizi P Salehi A Etemadi S Zahedi-Asl 2003 Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study Diabetes Res Clin Pract 61 29 37 12849921 10.1016/S0168-8227(03)00066-4 (Pubitemid 36808841)
12. F Facchini YD Chen CB Hollenbeck GM Reaven 1991 Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration JAMA 266 3008 3011 1820474 10.1001/jama.266.21. 3008 1:CAS:528:DyaK38Xls1yrtLg%3D
13. F Saggiani S Pilati G Targher P Branzi M Muggeo E Bonora 1996 Serum uric acid and related factors in 500 hospitalized subjects Metabolism 45 1557 1561 8969292 10.1016/S0026-0495(96)90188-2 1:CAS:528:DyaK2sXhsVej (Pubitemid 26424587)
14. E Bonora G Targher MB Zenere, et al. 1996 Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona Young Men Atherosclerosis Risk Factors Study Int J Obes Relat Metab Disord 20 975 980 8923153 1:STN:280: DyaK2s%2FotF2isg%3D%3D (Pubitemid 26366450)
15. VG Athyros ES Ganotakis M Elisaf DP Mikhailidis 2005 The prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitions Curr Med Res Opin 21 1157 1159 16083523 10.1185/030079905X53333 (Pubitemid 41140717)
16. PZ Zimmet VR Collins GK Dowse, et al. 1994 Is hyperinsulinaemia a central characteristic of a chronic cardiovascular risk factor clustering syndrome? Mixed findings in Asian Indian, Creole and Chinese Mauritians. Mauritius Noncommunicable Disease Study Group Diabet Med 11 388 396 8088112 10.1111/j.1464-5491.1994.tb00291.x 1:STN:280:DyaK2cznsVWhsg%3D%3D (Pubitemid 24196065)
17. SG Tsouli EN Liberopoulos DP Mikhailidis VG Athyros MS Elisaf 2006 Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander? Metabolism 55 1293 1301 16979398 10.1016/j.metabol.2006.05. 013 1:CAS:528:DC%2BD28Xps1ajtb4%3D (Pubitemid 44354944)
18. TW Yoo KC Sung HS Shin, et al. 2005 Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome Circ J 69 928 933 16041161 10.1253/circj.69.928 1:CAS:528:DC%2BD2MXpsVamtLg%3D (Pubitemid 41124260)
19. SD Lin DH Tsai SR Hsu 2006 Association between serum uric acid level and components of the metabolic syndrome J Chin Med Assoc 69 512 516 17116612 10.1016/S1726-4901(09)70320-X 1:CAS:528:DC%2BD2sXitFCitQ%3D%3D
20. EJ Boyko M de Courten PZ Zimmet P Chitson J Tuomilehto KG Alberti 2000 Features of the metabolic syndrome predict higher risk of diabetes and impaired glucose tolerance: a prospective study in Mauritius Diabetes Care 23 1242 1248 10977013 10.2337/diacare.23.9.1242 1:STN:280:DC%2BD3M%2Fls1ShtQ%3D%3D
21. Y Taniguchi T Hayashi K Tsumura G Endo S Fujii K Okada 2001 Serum uric acid and the risk for hypertension and type 2 diabetes in Japanese men: the Osaka Health Survey J Hypertens 19 1209 1215 11446710 10.1097/00004872- 200107000-00005 1:CAS:528:DC%2BD3MXltVGktr8%3D (Pubitemid 32595276)
22. Expert Committee on the diagnosis, classification of diabetes mellitus 1997 Report of the expert committee on the diagnosis and classification of diabetes mellitus Diabetes Care 20 1183 1197
23. R Meshkani M Taghikhnai B larijani Sh Khatami E Khoshbin K Adeli 2006 The relationship between homeostasis model assessment and cardiovascular risk factors in Iranian subjects with normal fasting glucose and normal glucose tolerance Clin Chim Acta 371 169 175 16714005 10.1016/j.cca.2006.03.018 1:CAS:528:DC%2BD28XotFKiurg%3D (Pubitemid 44162916)
24. A Onat GS Avc M Senocak E Ornek Y Gozukara 1992 Plasma lipid and their interaction in Turkish adults J Epidemiol Community Health 45 470 476 10.1136/jech.46.5.470
25. Expert Committee on the diagnosis, classification of diabetes mellitus 1997 Report of the expert committee on the diagnosis and classification of diabetes mellitus Diabetes Care 20 1183 1197
26. S Genuth KG Alberti P Bennett, et al. 2003 Expert committee on the diagnosis and classification of diabetes mellitus: follow-up report on the diagnosis of diabetes mellitus. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Diabetes Care 26 3160 3167 14578255 10.2337/diacare.26.12.3331 (Pubitemid 37466897)
27. B Goke 1998 Implications of blood glucose, insulin resistance and beta-cell function in impaired glucose tolerance Diabetes Res Clin Pract 40 S15 S20 9740497 10.1016/S0168-8227(98)00037-0 1:CAS:528:DyaK1cXktFKnu7Y%3D
28. M Heinig RJ Johnson 2006 Role of uric acid in hypertension, renal disease, and metabolic syndrome Cleve Clin J Med 73 1059 1064 17190309 10.3949/ccjm.73.12.1059 (Pubitemid 44883981)
29. T Nakagawa H Hu S Zharikov, et al. 2006 A causal role for uric acid in fructose-induced metabolic syndrome Am J Physiol Renal Physiol 290 F625 F631 16234313 10.1152/ajprenal.00140.2005 1:CAS:528:DC%2BD28XjtFCnsbY%3D (Pubitemid 43724964)
30. S Baldus R Koster P Chumley T Heitzer, et al. 2005 Oxypurinol improves coronary and peripheral endothelial function in patients with coronary artery disease Free Radic Biol Med 39 1184 1190 16214034 10.1016/j.freeradbiomed.2005. 06.004 1:CAS:528:DC%2BD2MXhtVymsrbL (Pubitemid 41407712)
31. K Nagahama K Iseki T Inoue T Touma Y Ikemiya S Takishita 2004 Hyperuricemia and cardiovascular risk factor clustering in a screened cohort in Okinawa, Japan Hypertens Res 27 227 233 15127879 10.1291/hypres.27.227 (Pubitemid 38594393)
32. N Nakanishi M Okamoto H Yoshida Y Matsuo K Suzuki K Tatara 2003 Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers Eur J Epidemiol 18 523 530 12908717 10.1023/A:1024600905574 1:CAS:528:DC%2BD3sXltVemsrc%3D (Pubitemid 36899556)
33. E Krishnan CK Kwoh HR Schumacher L Kuller 2007 Hyperuricemia and incidence of hypertension among men without metabolic syndrome Hypertension 49 298 303 17190877 10.1161/01.HYP.0000254480.64564.b6 1:CAS:528: DC%2BD2sXivFKrtw%3D%3D (Pubitemid 46143005)
34. A Coutinho Tde ST Turner PA Peyser LF Bielak PF Sheedy IJ Kullo 2007 Associations of serum uric Acid with markers of inflammation, metabolic syndrome, and subclinical coronary atherosclerosis Am J Hypertens 20 83 89 17198917 10.1016/j.amjhyper.2006.06.015 (Pubitemid 46014067)
35. E Bonora S Kiechl J Willeit, et al. 1998 Prevalence of insulin resistance in metabolic disorders: the Bruneck Study Diabetes 47 1643 1649 9753305 10.2337/diabetes.47.10.1643 1:CAS:528:DyaK1cXmtlSmtLw%3D (Pubitemid 28445355)
36. A Onat H Uyarel G Hergenc, et al. 2006 Serum uric acid I is a determinant of metabolic syndrome in a population-based study Am J Hypert 19 1055 1062 10.1016/j.amjhyper.2006.02.014 1:CAS:528:DC%2BD28XhtVCrtb7M (Pubitemid 44485960)
37. H Nan Q Qiao S Soderberg, et al. 2008 Serum uric acid and components of the metabolic syndrome in non-diabetic populations in Mauritian Indians and Creoles and in Chinese in Qingdao, China Metab Syndr Relat Disord 6 47 57 18370836 10.1089/met.2007.0028 1:CAS:528:DC%2BD1cXislGrtL0%3D (Pubitemid 351363915)
38. A Bedir M Topbas F Tanyeri M Alvur N Arik 2003 Leptin might be a regulator of serum uric acid concentration in human Jpn Heart J 44 527 536 12906034 10.1536/jhj.44.527 1:CAS:528:DC%2BD3sXmvFymt7Y%3D (Pubitemid 41518990)
39. N Nakanishi K Suzuki H Kawashimo K Nakamura K Tatara 1999 Serum uric acid: correlation with biological, clinical and behavioral factors in Japanese men J Epidemiol 9 99 106 10337082 1:STN:280:DyaK1M3mvFektA%3D%3D
40. IH Fox D John S DeBruyne I Dwosh EB Marliss 1985 Hyperuricemia and hypertriglyceridemia: metabolic basis for the association Metabolism 34 741 746 4021806 10.1016/0026-0495(85)90025-3 1:CAS:528:DyaL2MXktlGltb8%3D (Pubitemid 15018616)
41. DG Cook AG Shaper DS Thelle TP Whitehead 1986 Serum uric acid, serum glucose and diabetes: relationships in a population study Postgrad Med J 62 1001 1006 3628142 10.1136/pgmj.62.733.1001 1:STN:280:DyaL2szhslehtQ%3D%3D (Pubitemid 17181719)
42. TP Whitehead I Jungner D Robinson W Kolar A Pearl A Hale 1992 Serum urate, serum glucose and diabetes Ann Clin Biochem 29 159 161 1626918
43. FJ Tinahones F Cardona G Rojo-Martínez, et al. 2008 Decreased levels of uric acid after oral glucose challenge is associated with triacylglycerol levels and degree of insulin resistance Brit J Nut 99 44 48 10.1017/S0007114507787470 1:CAS:528:DC%2BD1cXit1OjtLw%3D (Pubitemid 350286137)
44. HK Choi ES Ford 2008 Haemoglobin A1c, fasting glucose, serum C-peptide and insulin resistance in relation to serum uric acid levels-the Third National Health and Nutrition Examination Survey Rheumatology 47 713 717 18390895 10.1093/rheumatology/ken066 1:CAS:528:DC%2BD1cXkvFymtLg%3D (Pubitemid 351619218)
45. T Nakagawa KR Tuttle RA Short RJ Johnson 2005 Fructose induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome Nat Clin Nephrol 1 80 86 10.1038/ncpneph0019 1:CAS:528:DC%2BD28Xot1eqtg%3D%3D
46. LK Chen MH Lin HY Lai SJ Hwang ST Chiou 2008 Uric acid: a surrogate of insulin resistance in older women Maturitas 59 55 61 18082342 10.1016/j.maturitas.2007.10.006 1:CAS:528:DC%2BD1cXhsVOmtLY%3D
47. TL Liou MW Lin LC Hsiao, et al. 2006 Is hyperuricemia another facet of the metabolic syndrome? J Chin Med Assoc 69 104 109 16599014 10.1016/S1726-4901(09)70186-8 1:CAS:528:DC%2BD28XjslWisbc%3D
48. WH Sheu YH Tseng 2006 Uric acid: an additional component of metabolic syndrome? J Chin Med Assoc 69 99 100 16599012 10.1016/S1726-4901(09)70184-4
49. S Ryu J Song BY Choi, et al. 2007 Incidence and risk factors for metabolic syndrome in Korean male workers, ages 30 to 39 Ann Epidemiol 17 245 252 17300957 10.1016/j.annepidem.2006.10.001 (Pubitemid 46454381)
50. X Sui TS Church RA Meriwether F Lobelo SN Blair 2008 Uric acid and the development of metabolic syndrome in women and men Metabolism 57 845 852 18502269 10.1016/j.metabol.2008.01.030 1:CAS:528:DC%2BD1cXmsVaqtL8%3D (Pubitemid 351697915)